Deadline: 16 Oct 2030
United Kingdom
Ref. No.: 20501640
EMD:Ref Document
Bid Value: Ref Document
1604 Days Left
Deadline: 23 Feb 2029
United Kingdom
Ref. No.: 20501627
EMD:Ref Document
Bid Value: Ref Document
1004 Days Left
Deadline: 23 Feb 2029
United Kingdom
Ref. No.: 20501603
EMD:Ref Document
Bid Value: Ref Document
1004 Days Left
Deadline: 23 Feb 2029
United Kingdom
Ref. No.: 20501563
EMD:Ref Document
Bid Value: Ref Document
1004 Days Left
Deadline: 31 Aug 2027
Germany
Ref. No.: 20500236
EMD:Ref Document
Bid Value: Ref Document
462 Days Left
Open House Pharmaceutical Discounts On The Active Ingredient Natalizumab S C Daring Form Atc L04Ag03
Deadline: 31 Aug 2027
Germany
Ref. No.: 20494511
EMD:Ref Document
Bid Value: Ref Document
462 Days Left
Deadline: 30 Sep 2026
United States
Ref. No.: 20486063
EMD:Ref Document
Bid Value: Ref Document
127 Days Left
Deadline: 31 Aug 2027
Germany
Ref. No.: 20485097
EMD:Ref Document
Bid Value: Ref Document
462 Days Left
Deadline: 31 Aug 2027
Germany
Ref. No.: 20480926
EMD:Ref Document
Bid Value: Ref Document
462 Days Left
Deadline: 31 Aug 2027
Germany
Ref. No.: 20477956
EMD:Ref Document
Bid Value: Ref Document
462 Days Left
Deadline: 31 Aug 2027
Germany
Ref. No.: 20472096
EMD:Ref Document
Bid Value: Ref Document
462 Days Left
Deadline: 31 Aug 2027
Germany
Ref. No.: 20468357
EMD:Ref Document
Bid Value: Ref Document
462 Days Left
Deadline: 30 Nov 2026
Australia
Ref. No.: 20446676
EMD:Ref Document
Bid Value: Ref Document
188 Days Left
Deadline: 31 Jul 2030
United States
Ref. No.: 20436774
EMD:Ref Document
Bid Value: Ref Document
1527 Days Left
Deadline: 22 Sep 2026
United States
Ref. No.: 20434733
EMD:Ref Document
Bid Value: Ref Document
119 Days Left